 year review invasive aspergillosis necropsy Between cases invasive aspergillosis consecutive necropsies incidence incidence immunosuppressed high risk patients cases spread lungs brain common site increase cases second half decade attributable start liver transplantation programme Liver transplant recipients patients haematological malignancies risk aspergillosis kidney transplant recipients solid malignancies chemotherapy risk haematogenous dissemination liver transplant recipients groups use high dose steroids anti-rejection treatment life cases need value necropsy